APTO

Aptose Biosciences, Inc.
APTO

Overview Fund Activity
Delisted

APTO was delisted on the 1st of April, 2025.

Back to rankings

24 hedge funds and large institutions have $1.72M invested in Aptose Biosciences, Inc. in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
-1
Holders Change %
-4%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SPC
Sigma Planning Corp
Michigan
$309K
2
Cetera Investment Advisers
Cetera Investment Advisers
Illinois
$35.4K
3
PP
PDS Planning
Ohio
$16.6K

Top Sellers

1
CC
Carlson Capital
Texas
$0
2
Morgan Stanley
Morgan Stanley
New York
$56.3K
3
AC
Annandale Capital
Texas
$44K
4
Citadel Advisors
Citadel Advisors
Florida
$42.6K
5
NCM
Nantahala Capital Management
Connecticut
$147K
Name Holding Trade Value Shares
Change 		Shares
Change %
Fidelity International
26
Fidelity International
Bermuda
$2 -$3 – –
Citigroup
27
Citigroup
New York
$2 -$3 – –
National Bank of Canada
28
National Bank of Canada
Quebec, Canada
$1 -$33 – –
CC
29
Carlson Capital
Texas
– -$246K -3,222 Closed
TSS
30
Two Sigma Securities
New York
– -$39.3K -516 Closed
UBS Group
31
UBS Group
Switzerland
– -$19.3K -253 Closed
1
2